| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/04/2008 | EP1927595A2 Salts of clopidogrel and process for preparation |
| 06/04/2008 | EP1926826A2 Class iia histone deacetylase (hdac) substrate |
| 06/04/2008 | EP1926738A1 Synthesis of cyclopentadienedithiophene derivatives |
| 06/04/2008 | EP1926737A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 06/04/2008 | EP1926736A1 Novel resinate complex of s-clopidogrel and production method thereof |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1611139B1 Methods of preparing olanzapine |
| 06/04/2008 | EP1469853B1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d-pyrimidine for treating of urinary incontinence |
| 06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/03/2008 | US7381585 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 05/29/2008 | WO2008064018A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers |
| 05/29/2008 | WO2008063670A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063669A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063667A1 Heterotricyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008062421A1 A process for preparing (s)-(+)-clopidogrel base and its salts |
| 05/29/2008 | WO2007072150A3 Piperidine derivatives |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | CA2670044A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670042A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670026A1 Heterotricyclic metalloprotease inhibitors |
| 05/29/2008 | CA2636242A1 Heterobicyclic thiophene compounds and methods of use |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1756118B1 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors |
| 05/28/2008 | CN101189242A Synthesis of deoxybiotinyl hexamethylenediamine-DOTA |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189240A Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 05/28/2008 | CN101189235A 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/28/2008 | CN101189007A Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN100390180C Clopidogrel and its salt preparing method |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/27/2008 | US7378532 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor |
| 05/22/2008 | WO2008059368A2 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008012413A3 Pyrimidinone derivatives and their use as a drug |
| 05/22/2008 | US20080119655 preparing biotin through intermediiate such as Di(imidazolidinylmethyl)disulfide compound; transformation of thiazole ring to imadazole ring with methyl mercaptan appendage |
| 05/22/2008 | US20080116452 Aromatic enediyne derivative, organic semiconductor thin film, electronic device and methods of manufacturing the same |
| 05/22/2008 | CA2669886A1 Compounds useful as protein kinase inhibitors |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/21/2008 | EP1923432A1 Method of staining substance having phosphate group |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184756A Isoflavonoid dimers |
| 05/21/2008 | CN101184746A Macrocyclic thiiranes |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375226 (6-Chloro-3,4-dihydro-1H-benzo[4,5]thieno[2,3-c]pyridin-2-yl)-(2-isopropoxy-5-methanesulfonyl-phenyl)-methanone; glyicne transporter 1 (GlyT-1) and N-methyl-D-aspartate (NMDA) receptors inhibitor; psychoses, schizophrenia, attention deficit disorders, Alzheimer's disease; cognition activator |
| 05/20/2008 | US7375109 Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2205664C Indole derivatives and medicinal use thereof |
| 05/15/2008 | WO2008057873A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057871A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008029350A3 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080113341 Fluorinated resorufin compounds and their application |
| 05/15/2008 | DE202006020224U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/14/2008 | EP1919924A2 Compounds and compositions as protein kinase inhibitors |
| 05/14/2008 | EP1919923A1 A process for making olanzapine form i |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | CN101177430A Hydrogenated pyridine derivative and method for preparing salt thereof |
| 05/13/2008 | US7371778 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 05/13/2008 | US7371755 Antiviral agents |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/08/2008 | WO2008053812A1 Cyanopyridine derivative and medicinal use thereof |
| 05/08/2008 | WO2008052444A1 Compounds with a six-membered heterocyclic ring, their preparing method and pharmaceutical use |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108611 Substituted thienopyrimidine kinase inhibitors |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108599 Heterocyclic Tetracyclic Tetrahydrofuran Derivatives As 5Ht2 Inhibitors In The Treatment Of Cns Disorders |
| 05/08/2008 | US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same |
| 05/08/2008 | DE202006020223U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/07/2008 | EP1918293A1 Process for the preparation of 6-substituted-4-oxo-thieno [2,3b]thiopyran-2-sulfonic acid |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917015A1 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 05/07/2008 | EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/07/2008 | CN101175749A Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386328C Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 05/06/2008 | US7368577 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| 05/06/2008 | US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists |
| 05/06/2008 | US7368475 high and selective activity against Cytomegalovirus |
| 05/06/2008 | US7368459 Heterocyclic compounds |
| 05/06/2008 | US7368455 2-(4-fluorophenyl)-3-[2-(2-methoxy-1-methylethylamino)pyrimidin-4-yl]-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-one; cytokines (interleukin-1, 6, 8 and Tumor Necrosis Factor- alpha) inhibitor; antiinflammatory and antiarthritic agents; osteoporosis, rheumatic diseases; antidiabetic |
| 05/06/2008 | US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/06/2008 | CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 05/02/2008 | WO2008051282A2 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 05/02/2008 | WO2008050853A1 Therapeutic agents for irritable bowel syndrome |